DMAA (Tag Archives)
Subscribe to PricePlow's Newsletter and DMAA Alerts
Melatonin and CBD Under Fire? Meet Pieter Cohen, the Grim Reaper of ‘Gray Area’ Ingredients
The Journal of the American Medicine Association (JAMA) recently published a study showing that the quality control on melatonin gummies in the United States may not be the best – unfortunately, only 12% of the products tested were FDA compliant.[1]
Reason being, the FDA generally allows a discrepancy of up to 10% between a product’s […]
Continue Reading →
DMAA Banned From Supplements: Hi-Tech Pharmaceuticals Loses Appeal
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
On August […]
Continue Reading →
Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma
All has been quiet on the DMAA front, pending Hi-Tech’s DMAA Lawsuit Appeal to the 11th Circuit, a decision we’re still waiting on after oral arguments were heard in August 2018.
We finally have a bit of an update, but it’s important to stress that Hi-Tech is still under an order from Judge Alan Braverman […]
Continue Reading →
DMAA FDA Lawsuit Appeal Oral Arguments: Hi-Tech Gets Their Day in Court
In March of 2018, we were left with Hi-Tech Pharmaceuticals’ appeal to the Eleventh Circuit court over their DMAA lawsuit against the FDA. Before we get into the update, a quick recap:
Hi-Tech appealed the ruling of district court judge Willis B. Hunt because he made his decision against them based upon information that neither[…]
Continue Reading →
Hi-Tech’s FDA DMAA Lawsuit Recap (Updated April 2020)
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
BREAKING (August […]
Continue Reading →
Hi-Tech Fights to Get its Confiscated DMAA Back (December 2017)
Update December 28, 2017: Hi-Tech Pharmaceuticals has appealed the Magistrate Judge’s decision denying their request to […]
Continue Reading →
Hi-Tech Pharmaceuticals Raided… Over RED YEAST RICE??
November 15, 2017 Update: Hi-Tech has filed a motion to amend the terms agreed to in this indictment (ie. they’re fighting […]
Continue Reading →
Is Angelo Lisi’s Geranium Study the WEAKEST Study Ever Published?
This is part five of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
In our previous article, we explored how the FDA wasted $2.3 million dollars on a study where researchers Mahmoud […]
Continue Reading →
Mahmoud ElSohly & Ikhlas Khan’s $2.3 Million FDA Tax Waste: Incomplete Results Published
This is part four of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
Given the rancid stench emanating from the previous two disastrous studies discussed on this blog (1. Mahmoud ElSohly and […]
Continue Reading →
The Daniel Armstrong / Ying Zhang DMAA Study Scandal at University of Texas Arlington
This is part three of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
In our previous article, we showed how paid researchers found DMAA but claimed that there was an “absense” of […]
Continue Reading →
